Resumen de acción EMBLA
Embla Medical hf., junto con sus filiales, suministra productos ortopédicos no invasivos en Europa, Oriente Medio, África, América y Asia-Pacífico.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Embla Medical hf.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | kr.29.20 |
| 52 Week High | kr.35.70 |
| 52 Week Low | kr.25.25 |
| Beta | 0.59 |
| 1 Month Change | -12.84% |
| 3 Month Change | 0.17% |
| 1 Year Change | -7.30% |
| 3 Year Change | -38.78% |
| 5 Year Change | -23.56% |
| Change since IPO | 430.91% |
Noticias y actualizaciones recientes
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 26
A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Recent updates
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 26A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E
Jan 21Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 03Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Nov 28Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Nov 08A Look At The Fair Value Of Össur hf. (CPH:OSSR)
Sep 23We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt
Aug 21Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital
Jul 18Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 14Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
May 19Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Mar 14A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 21These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well
Dec 22There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Dec 07Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?
Sep 21Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Sep 02Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Aug 16Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 16Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends
Jun 01Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?
May 08Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around
Feb 22Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report
Feb 03Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Nov 25Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Oct 17Is Össur hf (CPH:OSSR) A Risky Investment?
Sep 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Aug 21Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Jul 11Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly
May 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
May 07There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Mar 25We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right
Mar 02We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt
Feb 22Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?
Feb 09What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?
Jan 26Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain
Jan 08
We're Watching These Trends At Össur hf (CPH:OSSR)
Dec 21Rentabilidad de los accionistas
| EMBLA | DK Medical Equipment | Mercado DK | |
|---|---|---|---|
| 7D | -5.2% | -2.4% | 1.7% |
| 1Y | -7.3% | -5.2% | 25.8% |
Rentabilidad vs. Industria: EMBLA obtuvo unos resultados inferiores a los del sector Danish Medical Equipment , que el año pasado arrojó un rendimiento del -5.8%.
Rentabilidad vs. Mercado: EMBLA obtuvo unos resultados inferiores a los del mercado Danish, que fue del 26.5% el año pasado.
Volatilidad de los precios
| EMBLA volatility | |
|---|---|
| EMBLA Average Weekly Movement | 4.8% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in DK Market | 9.5% |
| 10% least volatile stocks in DK Market | 2.9% |
Precio estable de las acciones: EMBLA no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de EMBLA (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1971 | 4,000 | Sveinn Solvason | www.ossur.com |
Embla Medical hf., junto con sus filiales, suministra productos ortopédicos no invasivos en Europa, Oriente Medio, África, América y Asia-Pacífico. Opera a través de tres segmentos: Prótesis, Ortesis y Soportes, y Atención al Paciente. El segmento de Prótesis ofrece productos mecánicos, como prótesis de miembros inferiores y prótesis de dedos; y productos biónicos controlados por microprocesador integrados en pies, rodillas, manos, forros, dedos y otros componentes.
Resumen de fundamentos de Embla Medical hf.
| Estadísticas fundamentales de EMBLA | |
|---|---|
| Capitalización bursátil | kr.12.47b |
| Beneficios(TTM) | kr.396.77m |
| Ingresos (TTM) | kr.5.61b |
31.4x
Ratio precio-beneficio (PE)2.2x
Ratio precio-ventas (PS)¿Está EMBLA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de EMBLA | |
|---|---|
| Ingresos | US$804.32m |
| Coste de los ingresos | US$310.36m |
| Beneficio bruto | US$493.96m |
| Otros gastos | US$437.03m |
| Beneficios | US$56.93m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
Jul 23, 2024
| Beneficios por acción (BPA) | 0.13 |
| Margen bruto | 61.41% |
| Margen de beneficio neto | 7.08% |
| Ratio deuda/patrimonio | 57.4% |
¿Cómo se ha desempeñado EMBLA a largo plazo?
Ver rendimiento histórico y comparativa